Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Per Jander: Uranium Still “Very Early” in Cycle, What to Watch in 2025

by admin March 15, 2025
March 15, 2025
Per Jander: Uranium Still “Very Early” in Cycle, What to Watch in 2025

Per Jander of WMC shares his thoughts on uranium, touching on supply, demand and prices.

In his view, the uranium market is still ‘very early’ in the current cycle.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Jeffrey Christian: Gold, Silver, PGMs in 2025; Plus Precious Metals Facts vs. Fiction
next post
US Electricity Demand to Surge — Nuclear Energy Key, but Supply Challenges Remain

Related Posts

Prismo Metals Closes Acquisition of Increased Interest in...

January 16, 2026

Coelacanth Energy

June 21, 2025

Project Update – Optimisation Underway Halleck Creek

July 18, 2025

Lac Carheil MRE to Benefit from Exceptional Assay...

July 18, 2025

ALTECH – CERENERGY Battery Prototype Reaches Key Milestones

September 12, 2025

Merger Discussions Between Brightstar and Aurumin

June 30, 2025

3 Key Themes from Fastmarkets’ 2025 Lithium Supply...

July 3, 2025

Maria Smirnova: Gold, Silver Price Drivers Still in...

February 4, 2025

Cobalt Market Update: Q1 2025 in Review

April 10, 2025

Lode Gold Closes $1.51 Million Upsized Private Placement

September 6, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved